| Secondary |
| Product Used For Unknown Indication |
24.3% |
| Drug Use For Unknown Indication |
13.3% |
| Cholelithiasis |
6.6% |
| Influenza |
6.6% |
| Hiv Infection |
6.1% |
| Cholecystectomy |
5.8% |
| Nausea |
5.2% |
| Hepatosplenic Candidiasis |
4.9% |
| T-cell Type Acute Leukaemia |
4.3% |
| Lymphoma |
3.2% |
| Haemorrhoids |
2.9% |
| Vomiting |
2.9% |
| Maternal Exposure During Pregnancy |
2.3% |
| Prophylaxis |
2.3% |
| Lip And/or Oral Cavity Cancer |
1.7% |
| Lung Infection |
1.7% |
| Pyrexia |
1.7% |
| Atrial Flutter |
1.4% |
| Radiation Oesophagitis |
1.4% |
| Antibiotic Therapy |
1.2% |
|
| Drug Eruption |
8.9% |
| Stevens-johnson Syndrome |
8.9% |
| Renal Failure Acute |
7.1% |
| Sinoatrial Block |
7.1% |
| Arrhythmia |
5.4% |
| Death |
5.4% |
| Drug Interaction |
5.4% |
| Peripheral Motor Neuropathy |
5.4% |
| Toxic Epidermal Necrolysis |
5.4% |
| Vision Blurred |
5.4% |
| Bradycardia |
3.6% |
| Cytolytic Hepatitis |
3.6% |
| Diarrhoea Haemorrhagic |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.6% |
| Limb Reduction Defect |
3.6% |
| Presyncope |
3.6% |
| Sinus Tachycardia |
3.6% |
| Swelling Face |
3.6% |
| Urinary Retention |
3.6% |
| Vomiting |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.0% |
| Nausea |
9.3% |
| Drug Use For Unknown Indication |
7.4% |
| Hypertension |
7.4% |
| Breast Cancer |
5.6% |
| Hiv Infection |
4.0% |
| Vomiting |
4.0% |
| Pain |
3.9% |
| Depression |
3.7% |
| Prophylaxis |
3.6% |
| Diarrhoea |
3.2% |
| Premedication |
3.0% |
| Acute Lymphocytic Leukaemia |
2.8% |
| Anxiety |
2.7% |
| Hepatitis C |
2.7% |
| Hiv Test Positive |
2.6% |
| Chemotherapy |
2.5% |
| Ovarian Cancer |
2.5% |
| Colorectal Cancer Metastatic |
2.1% |
| Abdominal Pain |
2.0% |
|
| Neutropenia |
10.6% |
| Thrombocytopenia |
10.6% |
| General Physical Health Deterioration |
9.1% |
| Renal Failure |
6.8% |
| Pancytopenia |
6.1% |
| Hyponatraemia |
5.3% |
| Weight Decreased |
5.3% |
| Electrolyte Imbalance |
4.5% |
| Rash |
4.5% |
| Septic Shock |
4.5% |
| Pancreatitis Acute |
3.8% |
| Renal Failure Acute |
3.8% |
| Venoocclusive Liver Disease |
3.8% |
| Cytolytic Hepatitis |
3.0% |
| Diarrhoea |
3.0% |
| Diplopia |
3.0% |
| Hypokalaemia |
3.0% |
| Sinoatrial Block |
3.0% |
| Somnolence |
3.0% |
| Trance |
3.0% |
|
| Interacting |
| Hepatosplenic Candidiasis |
100.0% |
|
| Drug Interaction |
35.3% |
| Sinoatrial Block |
29.4% |
| Arrhythmia |
11.8% |
| Atrioventricular Block Second Degree |
11.8% |
| Sinus Bradycardia |
5.9% |
| Sinus Tachycardia |
5.9% |
|
